MedDataX Logo

Fractional Nonablative 1540 nm Laser Resurfacing for Burn Scars- A Randomised Controlled Trial

NCT ID: NCT00689650

Last Updated: 2008-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2007-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective was to evaluate the efficacy of 1540 nm fractional laser treatment of mature burn scars.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Burn Scar Patients

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Group Type EXPERIMENTAL

1540 nm fractional laser

Intervention Type DEVICE

B

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

1540 nm fractional laser

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Burn scars with and without previous skin grafting.

Exclusion Criteria

* A tendency to produce hypertrophic scars or keloids,
* Previous treatment with dermabrasio, chemical peel, filler, laser treatment or Intense Pulsed Light (IPL) of study areas,
* Photosensitivity,
* Pregnancy or lactation,
* Current anticoagulative medication,
* Oral retinoid drugs within the past 6 months,
* Pigmentation after recent exposure to sun or solarium,
* Patients not considered to be able to follow the treatment protocol.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Bispebjerg Hospital

OTHER

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bispebjerg University Hospital

Copenhagen NV, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

H-D-2007-0094

Identifier Type: -

Identifier Source: org_study_id